Jun. 30 at 6:48 PM
$TLSA
If you are looking for somewhere to invest, take a look at Tiziana:
- fully human monoclonal antibody with perfect safety record. Partly due to is nasal application rather than intravenous.
- indications include SPMS. Alzheimer’s, MSA, ALS, traumatic brain injury and long covid
- SPMS phase 2a data due out in September/October. Accordingly to the CEO, multiple big pharma have asked to see the data first, before it is released publically. Following Sanofi’s phase 3 trial failure, I wouldn’t be surprised if they were in the bidding
- the CEO is a big hittter and recently personally invested multiple millions into the company. The Executive Chairman also owns more that 35% of the company. Huge alignment
It is just a huge opportunity IMO. Massive countdown to SPMS data which will be a huge inflexion point.
See you all there! 🔥
$XBI $SLS $LABU
